reference/31842557

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31842557

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	140
issn	1476-5500 0929-1903
issueIdentifier	1-2
pageRange	126-140
publicationName	Cancer Gene Therapy
startingPage	126
bibliographicCitation	Li D, Wang T, Sun FF, Feng JQ, Peng JJ, Li H, Wang C, Wang D, Liu Y, Bai YD, Shi ML, Zhang T. MicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinoma. Cancer Gene Ther. 2021 Feb;28(1-2):126–40. PMID: 32616906; PMCID: PMC7886652.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_840554fd804bcf7f3b216d8999d37ed2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e19e3ab3d3249c15dc5fc291f856bbcb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_895cda9aecebf911052dd3a29375511b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b888418c3a3e793fd8f49f4d39223006 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d42059ea0c097efdca91edbc9f59fab3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83e47b32a5a21e1ffba5135d712557ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8da849a0bac870015b26c459b5f80f3c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_269962d54737d4d7b89127c968bbd7f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9dc01eaca0801e99046129956febc31c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f50dc1d3c70ed45f75a3953f0d0e82e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ab7fba54f502cc2235d3783a43d83dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9984-5924
date	2020-07-03^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/32616906 https://doi.org/10.1038/s41417-020-0191-x https://pubmed.ncbi.nlm.nih.gov/PMC7886652
isPartOf	https://portal.issn.org/resource/ISSN/0929-1903 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8745 https://portal.issn.org/resource/ISSN/1476-5500
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	MicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinoma
discusses	http://id.nlm.nih.gov/mesh/M0407989 http://id.nlm.nih.gov/mesh/M0536084 http://id.nlm.nih.gov/mesh/M0446095
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D035683Q000378 http://id.nlm.nih.gov/mesh/D006528Q000188 http://id.nlm.nih.gov/mesh/D008113Q000098 http://id.nlm.nih.gov/mesh/D000077157Q000494 http://id.nlm.nih.gov/mesh/D006528Q000098 http://id.nlm.nih.gov/mesh/D008113Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D009389Q000378 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009389Q000473 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D009389Q000235 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D006528Q000378 http://id.nlm.nih.gov/mesh/D006528Q000235 http://id.nlm.nih.gov/mesh/D008113Q000235 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D051381 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D017207 http://id.nlm.nih.gov/mesh/D008113Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0c63bf9a73fdec18acb2404f288fccd6 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_04007e4018920926e5eebc65dd327dd5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6c56dc6d32054325fdc576845aee7bc1

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID494324

Showing number of triples: 1 to 64 of 64.